References
- American Cancer Society. Breast cancer facts and figures
2010. Atlanta American Cancer Society.2010.
- Lansac J, Lecomte P et Marret H. Gynécologie pour
le praticien. 8e édition, Elsevier Masson, Paris, 2012.r
- Mignotte H. maladies du sein. 2e édition. Elsevier Masson, 2011.
- Dignostic and therapeutical management of malignant pleural effusion, Tassi, Ann. Onc 2006 Mar, 17. Google Scholar
- Tamoxifen for early breast cancer: an overview of
the randomised trials. Early Breast Cancer Trialists'
Collaborative Group. Lancet. 1998 May 16;351(9114):1451-67. PubMed | Google
Scholar
- Brauner M, Brillet PY. Other malignant tumors of
the pleura. Rev Pneumol Clin. 2006 Apr;62(2):124-7. PubMed | Google
Scholar
- Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn
KL. Arm edema in breast cancer patients. J Natl Cancer
Inst. 2001 Jan 17;93(2):96-111. PubMed | Google
Scholar
- Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphoedema. Cancer. 1998; 83(12 Suppl): 2776-81. PubMed | Google Scholar
- Arrault M et Vigne S. facteurs de risques de développement d?un lympoedeme du membre supérieur après traitement du cancer du sein. Bull Cancer. 2006 ; 93 (10) : 1001-6. PubMed | Google Scholar
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survi- val : an overview of the randomised trials. Lancet. 2005 ; 365 (9472) : 1687-17717. Google Scholar
- Baum M, Hackshaw A, Houghton J et al. Adjuvant goserelin in pre-menopausal patients with early breast cancer: results from the ZIPP study. Eur J Cancer. 2006 ; 42 (7) : 895-904. PubMed | Google Scholar
- Fisher B, Dignam J, Bryant J, Wolmark N.. Five
versus more than five years of tamoxifen for lymph
node-negative breast cancer: updated findings from
the National Surgical Adjuvant Breast and
Bowel Project B-14 randomized trial. J Natl Cancer
Inst. 2001 May 2;93(9):684-90. Google
Scholar
- Sacco M, Valentini
M, Belfiglio M, Pellegrini F, De Berardis G, et al.
Randomized trial of 2 versus 5 years of adjuvant
tamoxifen for women aged 50 years or older with early
breast cancer: Italian Interdisciplinary Group Cancer
Evaluation Study of Adjuvant
Treatment in Breast Cancer 01. J Clin Oncol. 2003
Jun 15;21(12):2276-81. Google
Scholar